Introduction {#s1}
============

Idiopathic ventricular arrhythmia is arrhythmia that can occur in the normal structured heart, without metabolic disturbance nor electrolyte disturbance. Ventricular premature contraction (VPC) and ventricular tachycardia (VT) in the normal structured heart may originate from the left ventricle (idiopathic left ventricular tachycardia/ILVT), ventricular outflow tracts or from other sites such as the mitral annulus, tricuspid annulus, papillary muscle and epicardial perivaskular. The estimated prevalence of VPC in patients with normal heart structure is about 1-4% of the general population \[[@R01]\], whereas the idiopathic VT is around 10% of the total patients referred to the arrhythmia center in United States \[[@R02]\] and 20% in Japan \[[@R03]\].

Triggered activity mechanism is thought to play a role in the progression of idiopathic outflow tract VPC to VT by the occurence of early afterdepolarization (EAD) in the phase 2 repolarization ([Fig. 1](#F1){ref-type="fig"}) which is transmitted transmurally \[[@R04], [@R05]\]. The functional reentry pathway exists due to the presence of Masonic Midmyocardial Moe (M) cells which during bradycardia or administration of certain drugs, has the ability to prolong its action potential duration over epicardial and endocardial cells \[[@R06]\]. The different action potential duration of epicardial cells, M cells and endocardial cells results in transmural dispersion of repolarization (TDR) \[[@R07]\].

![EAD-induced trigger initiated long run of polymorphic VT in arterially perfused rabbit left ventricle pretreated with dl-sotalol 100 mmol/L \[[@R05]\].](cr-09-215-g001){#F1}

Several studies found that increased TDR was associated with the occurrence of VT. Some pathological conditions such as long QT syndrome, Brugada syndrome and post-myocardial infarction may affect the normal pattern of repolarization resulting in increased TDR and VT risk \[[@R08]\]. Increased TDR can be detected by prolongation of the Tpeak-Tend (Tp-Te) interval on 12-lead electrocardiogram (ECG). Tp-Te is the time interval measured from the peak of the T wave to the end of the T wave, which coincides with the repolarization time of epicardium cells until the completion of M cell repolarization \[[@R9]\].

Ratio of Tp-Te/QT has been reported from previous studies could serve as arrhythmogenesis index, reflecting VT susceptibility. The Tp-Te/QT ratio takes into account TDR and compares TDR to the total duration of repolarization time \[[@R10]\]. Increased Tp-Te/QT ratio in studies of Brugada syndrome, long QT syndrome, short QT syndrome and obstructive hypertrophy cardiomyopathy has shown association with ventricular arrhythmia or sudden death \[[@R11], [@R12]\]. This study aims to identify the association between Tp-Te/QT ratio with VT incidence in idiopathic outflow tract VPC.

Materials and Methods {#s2}
=====================

This study was an observational study with cross sectional design, with the subject of idiopathic outflow tract VPC patients in Cardiology Department, Dr. Sardjito Hospital, Yogyakarta. The inclusion criteria were: 1) Idiopathic outflow tract VPC patients; 2) Normal ejection fraction; 3) Patients with age ≥ 18 years. Exclusion criteria were: 1) Chronic heart failure; 2) Chronic renal failure; 3) Supraventricular tachycardia (SVT); 4) Primary valvular heart disease; 5) Hypertrophy obstructive cardiomyopathy; 6) Conduction disturbance of His bundles; 7) Pulmonary embolism; 8) Myocarditis; 9) ECG records can not be interpreted e.g. undocumented, atrial fibrillation, flat T wave, artifact, and multiphasic.

Subject data were retrieved retrospectively in Medical Record Installation and Cardiology Department of Dr. Sardjito Hospital, Yogyakarta, from ECG records, echocardiogram, treadmill test (TMT), coronary computed tomography (CT) scan, Holter monitor and electrophysiology study. The samples data were recorded during February 2013 until July 2017. Events of spontaneous VT were tracked from ECG, TMT or Holter monitor data. ECG was performed with standard 12-lead ECG with speed setting 25 mm/s and gain 10 mm/mV. The TMT was done in Bruce method using a GE T2100 treadmill manufactured by General Electric Company. Holter monitor recording was performed 24 h with BTL 08 manufactured by BTL Corporate. VT could also be triggered by programmed electrical stimulation (PES) during electrophysiology studies.

All patient data were recorded in Case Report Form (CRF). Records of ECG was scanned for digital processing. Tp-Te/QT was defined as the time from the peak of T wave to the intersection between the tangent and isoeectric line, divided with QT interval. Measurement of Tp-Te/QT ratio in leads V4, V5 and V6 was done in tangent method ([Fig. 2](#F2){ref-type="fig"}) \[[@R10]\]. Measurements of Tp-Te and QT values were performed using ImageJ program. A single-blind obeserver performed the ECG measurement and previously tested with Kappa. The kappa value for intra and inter-observer variability were 0.826 and 0.783 respectively.

![Tp-Te/QT ratio measurement \[[@R10]\].](cr-09-215-g002){#F2}

Statistical analysis was performed using SPSS for Windows software version 22.0. A comparative analysis was done in independent *t*-test to compare Tp-Te/QT ratio between groups with VT event group and those without VT events. Ratio of Tp-Te/QT then was classified into normal (\< 0.25) and increased (\> 0.25) groups. The hypothesis test was performed in Chi-square test.

Ethics {#s2a}
------

Research was conducted after receiving a permission from Medical Faculty of Universitas Gadjah Mada/Dr. Sardjito General Hospital Ethical Commitee.

Results {#s3}
=======

Among 64 idiopathic VPC patients, 46 patients were recruited based on the inclusion and exclusion criteria. ECG samples of VPC and VT patients could be seen in [Figure 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}. There were 11 patients with incomplete data and seven patients which were loss of follow-up. There were 32 (69.6%) female patients and 14 (30.4%) male patients. Mean age in all subjects was 44.59 ± 10.939 years. The coexisting disease in the study subjects were hypertension in 15 patients (32.6%) with left ventricular hypertrophy in five patients (10.9%), while diabetes mellitus (DM) was present in four patients (8.7%) and no SVT was observed. All patients in the study sample were normokinetic and had normal ejection fraction with mean 63.6±6.099%. The basic characteristics of the patient can be seen from [Table 1](#T1){ref-type="table"}.

![ECG from idiopathic outflow tract VPC patient.](cr-09-215-g003){#F3}

![ECG from idiopathic outflow tract VT patient.](cr-09-215-g004){#F4}

###### Basic Characteristics of the Idiopathic Outflow Tract VPC Subjects (N = 46)

  Variables                                               Value (n = 46)
  ------------------------------------------------------- ----------------
  Sex                                                     
    Female; n (%)                                         32 (69.6%)
    Male; n (%)                                           14 (30.4%)
  Age mean ± SD (year)                                    44.59 ± 10.939
  Comorbidities                                           
    Diabetes mellitus; n (%)                              4 (8.7%)
    Hypertension; n (%)                                   15 (32.6%)
    Left ventricular hypertrophy; n (%)                   5 (10.9%)
    SVT; n (%)                                            0 (0%)
  Ejection fraction (%)                                   63.6±6.099
  Clinical complaints                                     
    Palpitation; n (%)                                    29 (63%)
    Chest pain; n (%)                                     7 (15.2%)
    Dizziness; n (%)                                      5 (10.9%)
    Fatigue; n (%)                                        1 (2.2%)
    Syncope; n (%)                                        2 (4.3%)
    Hemodynamic disturbance; n (%)                        2 (4.3%)
  Antiarrhythmic drugs consumption during ECG recording   
    Bisoprolol; n (%)                                     5 (10.8%)
    Metoprolol; n (%)                                     1 (2.1%)
    Verapamil; n (%)                                      1 (2.1%)
  Antihypertension drugs                                  
    Ramipril; n (%)                                       3 (6.3%)
    Valsartan; n (%)                                      7 (15.2%)
    Candesartan; n (%)                                    4 (8.6%)
    Irbesartan; n (%)                                     1 (2.1%)
  Tp-Te                                                   
    Lead V4 ± SD (ms)                                     92.09 ± 16.52
    Lead V5 ± SD (ms)                                     94.50 ± 14.84
    Lead V6 ± SD (ms)                                     91.66 ± 17.23
  QT                                                      
    Lead V4 ± SD (ms)                                     408.93 ± 40.05
    Lead V5 ± SD (ms)                                     413.32 ± 37.02
    Lead V6 ± SD (ms)                                     409.55 ± 40.33
  Tp-Te/QT                                                
    Lead V4 ± SD (ms)                                     0.225 ± 0.037
    Lead V5 ± SD (ms)                                     0.228 ± 0.031
    Lead V6 ± SD (ms)                                     0.223 ± 0.036

ECG: electrocardiogram; SD: standard deviation; SVT: supraventricular tachycardia.

Clinical complaints experienced were mostly palpitation in 29 patients (63%) while unstable VT with hemodynamic disorders occured in two (4.3%) cases. Some ECGs were recorded at the time when patients were taking antiarrhythmic drugs i.e. bisoprolol in five (10.8%) patients, metoprolol in one (2.1%) patient, and verapamil also in one (2.1%) patient. The use of antihypertensive drugs was found mostly from angiotensin converting enzyme (ACE) inhibitor and angiotensin receptor blocker (ARB) class.

Based on VT incidence, 28 VT patients and 18 non-VT patients ([Table 2](#T2){ref-type="table"}) were found. Hypertension was more prevalent in the group with the VT incidence (P = 0.003; 95% CI). The incidence of spontaneous VT occured in 21 patients (75%) and the rest experienced VT induced during electrophysiological studies. The most common arrhythmia source was originated from the septal right ventricular outflow tract (RVOT) with a percentage of 50% (nine patients) in the non-VT group and 25% (seven patients) in the VT group, followed by anteroseptal RVOT, posteroseptal RVOT and free wall. The LVOT (left ventricular outflow tract) area as the source of arrhythmia activity was obtained in only one subject.

###### Characteristics of Research Subjects Based on VT Incidence (N = 46)

  Variables                               Without VT (n = 18)   With VT (n = 28)   P
  --------------------------------------- --------------------- ------------------ ------------
  Sex                                                                              
    Female; n (%)                         11 (69.6%)            21 (75%)           0.502
    Male; n (%)                           7 (30.4%)             7 (25%)            
  Age, mean ± s.d. (year)                 40.5 ± 11.284         47.21 ± 10.049     0.41
  Comorbidities                                                                    
    Diabetes mellitus; n (%)              1 (5.8%)              3 (10.7%)          0.944
    Hypertension; n (%)                   2 (11.1%)             13 (46.4%)         0.030\*
    Left ventricular hypertrophy; n (%)   2 (11.6%)             4 (14.3%)          0.634
    SVT; n (%)                            0 (0%)                0 (0%)             \-
  Ejection fraction                       63.28 ± 2.824         63.68 ± 7.484      0.829
  Drug consumption during ECG                                                      
    Verapamil; n (%)                      0 (0%)                1 (3.5%)           1
    Bisoprolol; n (%)                     2 (11.1%)             5 (17.8%)          1
    Metoprolol; n (%)                     1 (5.5%)              0 (0%)             0.391
  Antihypertension therapy                                                         
    Ramipril                              1 (5.5%)              2 (7.1%)           1
    Valsartan                             1 (5.5%)              6 (21.4%)          0.297
    Candesartan                           0 (0%)                4 (14.3%)          0.891
    Irbesartan                            0 (0%)                1 (3.5%)           1
  VT incidence                                                                     
    Spontaneous VT                                              21 (75%)           
    Induced VT                                                  7 (25%)            
  Types of VT                                                                      
    Nonsustained VT                       \-                    16 (57.1%)         
    Sustained VT                          \-                    10 (35.7%)         
    Unstable VT                           \-                    2 (7.2%)           
  Arrhythmia source                                                                
    Septal RVOT                           9 (50%)               7 (25%)            0.502
    Anteroseptal RVOT                     2 (11.1%)             3 (10.6%)          1
    Posteroseptal RVOT                    1 (5.6%)              2 (7.2%)           1
    Basal septal RVOT                     1 (5.6%)              1 (3.6%)           0.39
    Anterior RVOT                         1 (5.6%)              0 (0%)             0.39
    Free wall RVOT                        2 (11.1%)             1 (3.6%)           0.552
    LVOT                                  1 (5.6%)              0 (0%)             0.391
  Tp-Te                                                                            
    Lead V4 ± SD (ms)                     75.83 ± 11.86         102.54 ± 8.76      \< 0.001\*
    Lead V5 ± SD (ms)                     80.50 ± 8.49          103.50 ± 10.34     \< 0.001\*
    Lead V6 ± SD (ms)                     74.76 ± 8.56          102.53 ± 11.67     \< 0.001\*
  QT                                                                               
    Lead V4 ± SD (ms)                     392.37 ± 39.33        419.58 ± 37.40     0.023\*
    Lead V5 ± SD (ms)                     399.37 ± 35.96        422.30 ± 35.44     0.039\*
    Lead V6 ± SD (ms)                     392.75 ± 33.99        420.35 ± 40.91     0.022\*
  Ratio Tp-Te/QT                                                                   
    Sandapan V4 ± SD (ms)                 0.194 ± 0.033         0.245 ± 0.025      \< 0.001\*
    Sandapan V5 ± SD (ms)                 0.202 ± 0.021         0.245 ± 0.024      \< 0.001\*
    Sandapan V6 ± SD (ms)                 0.191 ± 0.022         0.245 ± 0.028      \< 0.001\*

VT: ventricular tachycardia; ECG: electrocardiogram; RVOT: right ventricular outflow tract; LVOT: left ventricular outflow tract; SVT: supraventricular tachycardia; SD: standard deviation.\*P \< 0.05; 95% CI.

The ECG markers for QT interval, Tp-Te interval and Tp-Te/QT ratio differed between groups of VT patients compared to non-VT groups. Longer QT interval was measured in the VT group (P = 0.023 for lead V4; P = 0.039 for lead V5; P = 0.022 for lead V6; 95% CI) and also for Tp-Te interval (P \< 0.001 for lead V4; P \< 0.001 for lead V5; P \< 0.001 for lead V6; 95% CI). In this study, mean of Tp-Te/QT ratio measured in those three leads were all found to be longer in the VT group (P ≤ 0.001; 95% CI) in comparison with the group without VT. The lead V4 Tp-Te/QT ratio mean value was around 0.245 ± 0.025 vs. 0.194 ± 0.033; 0.245 ± 0.024 vs. 0.202 ± 0.021 in lead V5; and 0.245 ± 0.028 vs. 0.191 ± 0.022 in lead V6.

In [Table 3](#T3){ref-type="table"} the subjects then were further categorized into normal (\< 0.25) and increased (\> 0.25) Tp-Te/QT ratio measured in leads V4, V5 and V6. There were 27 patients with normal and 11 patients with increased Tp-Te/QT ratio in lead V4, while in leads V5 and V6 were the same with 33 normal patients and 13 patients with increased Tp-Te/QT ratio. All groups were dominated by female, except in the group with increased Tp-Te/QT ratio in lead V4 (45.5% female) though it was not significantly different (P = 0.106; 95% CI). Mean of age were all around 40 years, mean ejection fraction (EF) was around 60%, comparable comorbidities and drug consumptions during ECG (P = 1.000; 95% CI).

###### Characteristics of Research Subjects Based on Tp-Te/QT Ratio Among Idiopathic Outflow Tract VPC Patients (N = 46)

  Variable                      Tp-Te/QT ratio in lead V4   Tp-Te/QT ratio in lead V5   Tp-Te/QT ratio in lead V6                                                                               
  ----------------------------- --------------------------- --------------------------- --------------------------- ---------------- ---------------- ------- ---------------- ---------------- -------
  Sex                                                                                                                                                                                           
    Female; n (%)               5 (45.5%)                   27 (77.1%)                  0.106                       8 (61.5%)        24 (72.7%)       0.699   8 (61.5%)        24 (72.7%)       0.699
    Male; n (%)                 6 (54.5%)                   8 (22.9%)                                               5 (38.5%)        9 (27.3%)                5 (38.5%)        9 (27.3%)        
  Age, mean ± SD (year)         42.82 ± 13.33               44.14 ± 10.23               0.545                       43.31 ± 12.493   45.09 ± 10.432   0.624   43.85 ± 12.536   44.88 ± 10.443   0.777
  Comorbidities                                                                                                                                                                                 
    Diabetes mellitus; n (%)    1 (25%)                     3 (75%)                     1                           1 (7.7%)         3 (9.1%)         1       1 (7.7%)         3 (9.1%)         1
    Hypertension; n (%)         5 (45.5%)                   10(28.6)                    0.501                       6 (46.2%)        9 (27.3%)        0.378   7 (53.8%)        8 (24.2%)        0.114
    LV hypertrophy; n (%)       2 (18.2%)                   4 (11.4%)                   0.947                       2 (15.4%)        4 (12.1%)        1       2 (15.4%)        4 (12.1%)        1
    SVT; n (%)                  0 (0%)                      0 (0%)                      \-                          0 (0%)           0 (0%)           \-      0 (0%)           0 (0%)           \-
  Ejection fraction             64.0 ± 6.928                63.37 ± 5.857               0.768                       64.0 ± 7.292     63.33 ± 5.611    0.741   64.31 ± 6.957    63.21 ± 5.749    0.586
  Drug consumption during ECG                                                                                                                                                                   
    Verapamil; n (%)            1 (2.8%)                    1 (2.8%)                    1                           1 (2.8%)         1 (2.8%)         1       1 (2.8%)         1 (2.8%)         1
    Bisoprolol; n (%)           1 (9.0%)                    3 (8.5%)                    1                           1 (9.0%)         3 (8.5%)         1       1 (9.0%)         3 (8.5%)         1
    Metoprolol; n (%)           0 (0%)                      1 (2.8%)                    1                           0 (0%)           1 (2.8%)         1       0 (0%)           1 (2.8%)         1
  Arrhythmia source                                                                                                                                                                             
    Septal RVOT                 1 (9.1%)                    13 (37.1%)                  0.165                       2 (15.4%)        12 (36.4%)       0.3     3 (23.1%)        11 (33.0%)       0.745
    Anteroseptal RVOT           0 (0%)                      5 (14.3%)                   0.44                        1 (7.7%)         4 (12.2%)        1       0 (7.7%)         5 (15.2%)        0.337
    Posteroseptal RVOT          2 (18.2%)                   1 (2.9%)                    0.273                       2 (15.4%)        1 (3.0%)         0.387   2 (15.4%)        1 (3.0%)         0.387
    Basal septal RVOT           0 (0%)                      1 (2.9%)                    1                           0 (0%)           1 (3.0%)         1       0 (0%)           1 (3.0%)         1
    Anterior RVOT               0 (0%)                      1 (2.9%)                    1                           0 (0%)           1 (3.0%)         1       0 (0%)           1 (3.0%)         1
    Free wall RVOT              1 (9.1%)                    2 (5.7%)                    1                           1 (7.7%)         2 (6.1%)         1       1 (7.7%)         2 (6.1%)         1
    LVOT                        0 (0%)                      1 (2.9%)                    1                           0 (0%)           1 (3.0%)         1       0 (0%)           1 (3.0%)         1

ECG: electrocardiogram; RVOT: right ventricular outflow tract; LVOT: left ventricular outflow tract; SVT: supraventricular tachycardia; SD: standard deviation. \*P \< 0.05; 95% CI.

From Chi-square analysis ([Table 4](#T4){ref-type="table"}), significant risk for VT incidence (P \< 0.005; 95% CI) was found for patients with increased Tp-Te/QT ratio with prevalence ratio (PR) of 2.059 in lead V4 measurement and PR of 2.200 for measurements either in V5 or V6. The Tp-Te/QT ratio either was performed in lead V4, V5 or V6 each gave very similar values (P \< 0.001; 95% CI) in one-way ANOVA ([Table 5](#T5){ref-type="table"}). Logistic regression test was done ([Table 6](#T6){ref-type="table"}) on variables that could potentially serve as confounding factors and lead V6 was chosen considering higher PR compared to lead V4 and was the lead used in the reference study by Gupta et al (2008) \[[@R10]\]. Taking into account hypertension as the confounding factor, Tp-Te/QT ratio in lead V6 gave insignificant result (PR 1.290; P = 0.639; 0.444 - 3.747).

###### Prevalence Ratio of Tp-Te/QT Ratio to VT Incidence Among Idiopathic Outflow Tract VPC Patients

  Variable         PR      95% CI          P
  ---------------- ------- --------------- ---------
  Tp-Te/QT ratio                           
    Lead V4        2.059   1.464 - 2.895   0.007\*
    Lead V5        2.200   1.514 - 3.197   0.002\*
    Lead V6        2.200   1.514 - 3.197   0.002\*

Tp-Te: Tpeak-Tend interval; PR: prevalence ratio. \*P \< 0.05; 95% CI.

###### Comparison of Tp-Te/QT Ratio Measurements in Leads V4, V5 and V6

  Lead   VT incidence   Mean Tp-Te/QT ± SD (ms)   P
  ------ -------------- ------------------------- ------------
  V4     Yes            0.245 ± 0.025             \< 0.001\*
         No             0.194 ± 0.033             \< 0.001\*
  V5     Yes            0.245 ± 0.024             \< 0.001\*
         No             0.202 ± 0.021             \< 0.001\*
  V6     Yes            0.245 ± 0.028             \< 0.001\*
         No             0.191 ± 0.022             \< 0.001\*

Tp-Te: Tpeak-Tend interval; SD: standard deviation. \*P \< 0.05; 95% CI.

###### Multivariate Analysis of VT Incidence in Idiopathic Outflow Tract VPC Patients

  Variable                   Exp (B)   95% CI          P
  -------------------------- --------- --------------- -------
  Hypertension               0.685     0.230 - 2.043   0.497
  Tp-Te/QT ratio (lead V6)   1.29      0.444 - 3.747   0.639

Tp-Te: Tpeak-Tend interval; Exp (B): exponential beta. \*P \< 0.05; 95% CI.

Discussions {#s4}
===========

In this study, subjects were dominated by female (69.6%) with mean age was 44.59 ± 10.939 years, the youngest subject was 22 years old, and the oldest one was 62 years old. Ventricular arrhythmia source was mostly coming from RVOT (96.8%) and only one patients had LVOT VPC. This findings matched with previous studies \[[@R02]-[@R04]\] stating that idiopathic RVOT arrhythmia happened two times more often in female and mostly occured in the third to fifth decade of life with mean presentation in the age of early 40s. Diabetes mellitus and hypertension were found to be the comorbidities in these patients, with more hypertensive patients were found in the VT group. Increased left ventricular mass in the hypertensive patients was thought could contribute to longer Tp-Te interval, though left ventricular hypertrophy was found similar in both groups ([Table 2](#T2){ref-type="table"}).

Increased dispersion of transmural repolarization in this study was characterized by the prolongation of Tp-Te interval. The Tp-Te interval in the leads V4, V5 or V6 from the bivariate test was found to be longer (P \< 0.001; 95% CI) in idiopathic outflow tract VPC experiencing VT either spontaneously or induced by electrophysiological studies ([Table 2](#T2){ref-type="table"}). Several previous clinical studies have found similar results which was the association between transmural repolarization dispersion using Tp-Te parameters with ventricular arrhythmias. During ventricular pacing, Tp-Te was found to be longer in VT-induceable patients compared with the non VT-induceable patients \[[@R13]\]. Patients with sustained VT and VF were also reported to have mean 12-lead Tp-Te values significantly longer compared to normal subjects \[[@R14]\]. In another study there was prolongation of lead V4 Tp-Te interval in patients experiencing VT-induced PES \[[@R15]\], while in another study it was found that Tp-Te was significantly longer in the idiopathic outflow tract VPC group who developed monomorphic VT \[[@R16]\].

In this study Tp-Te/QT ratio of leadsV4, V5 and V6 were all significantly longer in the group of patients with VT compared with those without VT incidence (P \< 0.001; 95% CI) in bivariate analysis. Based on references from studies by Gupta et al \[[@R10]\], the normal range values for Tp-Te/QT ratio was from 0.15 - 0.25 with median 0.21 and mean 0.21 ± 0.003. The research subjects in this study were then divided into two groups: those with normal Tp-Te/QT ratio (\< 0.25) and increased (\> 0.25) based on measurements done in leads V4, V5 and V6. No significantly different baseline characteristics of patients were found between the two groups ([Table 3](#T3){ref-type="table"}).

Measurement of Tp-Te/QT ratio was performed on leads V4, V5 and V6 with no significant difference (P \< 0.001; 95% CI). One-way ANOVA tests showed that V4, V5 and V6 can be used each equally strong in distinguishing idiopathic outflow tract VPC patients experiencing VT events and those without VT events ([Table 5](#T5){ref-type="table"}). In this study increased Tp-Te/QT ratio in leads V4, V5 or V6 was found to have elevated risk for VT incidence. Increased Tp-Te/QT ratio in lead V4 has 2.059 times the risk to experience VT incidence compared with normal Tp-Te/QT, while the VT risk was slightly higher as 2.200 times, if increased Tp-Te/QT ratio was found in leads V5 and V6. The measurements in leads V4, V5 and V6 gave similar Tp-Te and Tp-Te/QT values, as evidenced with significant bivariate study analysis ([Table 2](#T2){ref-type="table"}) and statistically significant PR test ([Table 4](#T4){ref-type="table"}). Unfortunately, this significant elevated risk was showed to be insignificant after considering hypertension as confounding factor ([Table 6](#T6){ref-type="table"}). In this study Tp-Te/QT ratio has not been able to serve as an independent predictor for VT incidence in idiopathic outflow tract VPC patients, due to the confounding effect of hypertension. Patients with increased Tp-Te/QT ratio who possesed hypertension as well, had elevated risk for VT but this cannot be applied for patients who were not hypertensive.

In the previous studies, it was found that Tp-Te/QT ratio could serve as an index of arithmogenesis to predict ventricular arrhythmia in certain susceptible populations. Ratio of Tp-Te/QT in long QT syndrome patients may act as a predictor of ventricular arrhythmia \[[@R11]\]. In a study of obstructive cardiomyopathy patients who experienced sudden cardiac death, an increased Tp-Te /QT ratio was observed \[[@R12]\]. Increased Tp-Te/QT ratio was also found in the study of VT-induced high risk Brugada syndrome patients \[[@R17], [@R18]\], while in other idiopathic VPC study Tp-Te/QT ratio was shorter after successful radiofrequency ablation therapy (P = 0.023; 95% CI) \[[@R19]\]. The application of this Tp-Te/QT ratio study was hopefully, and could be used in the peripheral or remote areas which are limited in resources, to distinguish idiopathic outflow tract VPC patients who had elevated risk for developing VT and could be managed further or referred to other cardiac centres.

Limitations {#s4a}
-----------

Study by Gupta et al (2008) \[[@R10]\] used references from normal population samples while in this study, normal patients without arrhythmia disorder as control group were not recruited. It is possible that there are actually variations in normal value in Indonesian population because: 1) Samples in reference studies were western populations; 2) The sample population in this study basically have an arrhythmia disorder in the form of an idiopathic outflow tract VPC so the range of values may not be equal with a completely normal population.

Conclusions {#s4b}
-----------

Increased Tp-Te/QT ratio in idiopathic outflow tract VPC patients is associated with higher prevalence ratio for VT incidence, but this association is not independent due to the influence of hypertension. Measurements of Tp-Te/QT ratio in leads V4, V5 and V6 can be used equally strong in predicting VT incidence.
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:   angiotensin converting enzyme
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:   angiotensin receptor blocker
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:   case report file

DM

:   diabetes mellitus

EAD

:   early after depolarization
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:   idiopathic left ventricular tachycardia
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:   left ventricular outflow tract

M cell
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QTd
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:   right ventricular outflow tract
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:   programmed electrical stimulation
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:   standard deviation
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:   supraventricular tachycardia

TdP

:   torsade de pointes

TDR

:   transmural dispersion of repolarisation

TMT

:   treadmill test

Tp-Te

:   Tpeak-Tend

VPC

:   ventricular premature contraction

VT

:   ventricular tachycardia
